The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
111843165 11184316 5 F 20150303 20160719 20150612 20160727 EXP JP-ROCHE-1563139 ROCHE 4.65 YR F Y 0.00000 20160727 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
111843165 11184316 1 PS RITUXAN RITUXIMAB 1 Intravenous (not otherwise specified) Y 103705 375 MG/M**2 SOLUTION FOR INFUSION /wk
111843165 11184316 2 SS RITUXAN RITUXIMAB 1 Intravenous (not otherwise specified) Y 103705 250 MG SOLUTION FOR INFUSION
111843165 11184316 3 SS Baktar SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral Y 0 1 DF TABLET
111843165 11184316 4 SS PREDNISOLONE. PREDNISOLONE 1 Oral Y 0 40 MG
111843165 11184316 5 SS PREDNISOLONE. PREDNISOLONE 1 Oral Y 0 40 MG
111843165 11184316 6 SS PREDNISOLONE. PREDNISOLONE 1 Oral Y 0 40 MG
111843165 11184316 7 SS PREDNISOLONE. PREDNISOLONE 1 Oral Y 0 20 MG
111843165 11184316 8 SS PREDNISOLONE. PREDNISOLONE 1 Oral Y 0 10 MG
111843165 11184316 9 C CALONAL ACETAMINOPHEN 1 Oral 0 250 MG
111843165 11184316 10 C BREDININ MIZORIBINE 1 Oral 0 150 MG
111843165 11184316 11 C NEORAL CYCLOSPORINE 1 Oral 0 60 MG
111843165 11184316 12 C POLARAMINE DEXCHLORPHENIRAMINE MALEATE 1 Oral 0 1.5 ML
111843165 11184316 13 C SOLU-MEDROL METHYLPREDNISOLONE SODIUM SUCCINATE 1 Intravenous (not otherwise specified) 0 25 MG
111843165 11184316 14 C BREDININ MIZORIBINE 1 Oral 0 100 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
111843165 11184316 1 Nephrotic syndrome
111843165 11184316 3 Infection prophylaxis
111843165 11184316 4 Nephrotic syndrome
111843165 11184316 10 Nephrotic syndrome
111843165 11184316 11 Nephrotic syndrome
111843165 11184316 14 Nephrotic syndrome

Outcome of event

Event ID CASEID OUTC COD
111843165 11184316 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
111843165 11184316 Abdominal pain
111843165 11184316 Blood pressure decreased
111843165 11184316 Cough
111843165 11184316 Granulocyte count decreased
111843165 11184316 Hair colour changes
111843165 11184316 Hypertension
111843165 11184316 Influenza
111843165 11184316 Nasopharyngitis
111843165 11184316 Pneumonia
111843165 11184316 Stomatitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
111843165 11184316 1 20150303 20150324 0
111843165 11184316 3 20150303 20150727 0
111843165 11184316 4 20150221 0
111843165 11184316 5 20150318 0
111843165 11184316 6 20150319 20150401 0
111843165 11184316 7 20150402 20150415 0
111843165 11184316 8 20150416 20150429 0
111843165 11184316 9 20150303 20150324 0
111843165 11184316 10 20140721 20150227 0
111843165 11184316 11 20130915 20150814 0
111843165 11184316 12 20150303 20150324 0
111843165 11184316 13 20150303 20150324 0
111843165 11184316 14 20150727 0